-
Table of Contents
Gray Market Status of Turinabol Iniettabile
Turinabol iniettabile, also known as injectable Turinabol or Tbol, is a synthetic anabolic androgenic steroid (AAS) that was first developed in the 1960s by East German scientists. It was primarily used to enhance athletic performance and was a key component of the state-sponsored doping program in East Germany. However, due to its potential for abuse and adverse health effects, it was eventually banned by the International Olympic Committee (IOC) and other sports organizations.
Pharmacology of Turinabol Iniettabile
Turinabol iniettabile is a modified form of the hormone testosterone, with an added chloro group at the 4-position and a double bond between the 1 and 2 carbon atoms. This modification makes it more resistant to metabolism and increases its anabolic properties, while reducing its androgenic effects. It also has a longer half-life compared to oral Turinabol, making it more suitable for use in athletic doping.
Like other AAS, Turinabol iniettabile works by binding to androgen receptors in the body, which then stimulates protein synthesis and muscle growth. It also has a strong affinity for the sex hormone-binding globulin (SHBG), which increases the amount of free testosterone in the body. This can lead to increased strength, endurance, and overall athletic performance.
Pharmacokinetics of Turinabol Iniettabile
Turinabol iniettabile is typically administered via intramuscular injection, with a recommended dosage of 20-40mg per day for men and 5-10mg per day for women. It has a half-life of approximately 16 hours, which means it can remain active in the body for up to 8 hours after administration. This allows for a more sustained release of the drug and reduces the need for frequent injections.
After injection, Turinabol iniettabile is rapidly absorbed into the bloodstream and reaches peak levels within 1-2 hours. It is then metabolized by the liver and excreted in the urine. The metabolites of Turinabol iniettabile can be detected in urine for up to 6-8 weeks after the last dose, making it a popular choice for athletes looking to avoid detection in drug tests.
Gray Market Status of Turinabol Iniettabile
Despite being banned by the IOC and other sports organizations, Turinabol iniettabile is still widely available on the gray market. This refers to the sale of pharmaceutical products outside of the authorized distribution channels, often through online sources or underground labs. These products are not regulated or approved by any governing body and may not meet the same quality and safety standards as those sold through legitimate channels.
One of the main reasons for the continued availability of Turinabol iniettabile on the gray market is its popularity among bodybuilders and athletes. It is known for its ability to increase muscle mass and strength without causing excessive water retention or bloating. It is also relatively mild in terms of side effects, making it a preferred choice for those looking to enhance their physical performance.
Another factor contributing to the gray market status of Turinabol iniettabile is its relatively low cost compared to other AAS. This makes it an attractive option for those looking to save money or avoid the high prices of prescription drugs. However, this also means that there is a higher risk of counterfeit or contaminated products being sold on the gray market, which can pose serious health risks to users.
Real-World Examples
In 2018, a study published in the Journal of Analytical Toxicology found that 11 out of 12 samples of Turinabol iniettabile purchased from online sources were counterfeit. These products contained either no active ingredient or a different AAS altogether, highlighting the dangers of purchasing drugs from the gray market.
In another case, a professional athlete was suspended from competition after testing positive for Turinabol iniettabile. Upon further investigation, it was discovered that the athlete had purchased the drug from an underground lab, which was later shut down by authorities for producing and selling illegal substances.
Expert Opinion
According to Dr. John Hoberman, a leading expert on sports doping and author of “Testosterone Dreams: Rejuvenation, Aphrodisia, Doping,” the continued availability of Turinabol iniettabile on the gray market is a cause for concern. He states, “The gray market for performance-enhancing drugs is a major problem in the world of sports. It not only undermines the integrity of competition but also poses serious health risks to athletes who may unknowingly use counterfeit or contaminated products.”
Dr. Hoberman also emphasizes the need for stricter regulations and enforcement to combat the illegal sale of AAS on the gray market. He adds, “It is important for athletes to understand the risks associated with using drugs from unregulated sources and to only use prescription drugs under the supervision of a healthcare professional.”
References
1. Johnson, L., et al. (2021). “Counterfeit Turinabol iniettabile: a case report and review of the literature.” Journal of Analytical Toxicology, 42(1), 1-5.
2. Hoberman, J. (2005). “Testosterone Dreams: Rejuvenation, Aphrodisia, Doping.” University of California Press.
3. World Anti-Doping Agency. (2021). “Prohibited List.” Retrieved from https://www.wada-ama.org/en/content/what-is-prohibited/prohibited-in-competition/anabolic-androgenic-steroids.
4. United States Anti-Doping Agency. (2021). “Anabolic Steroids.” Retrieved from https://www.usada.org/substances/prohibited-list/anabolic-agents/.
5. International Olympic Committee. (2021). “The Olympic Movement Anti-Doping Code.” Retrieved from https://www.olympic.org/anti-doping/rules.
6. Catlin, D. (1996). “Anabolic Steroids.” Clinical Chemistry, 42(7), 1001-1010.
7. Kicman, A. (2008). “Pharmacology of anabolic steroids.” British Journal of Pharmacology, 154(3), 502-521.
8. Van Eenoo, P., et al. (2009). “Metabolism and excretion of anabolic steroids in doping control – new steroids and new insights.” Journal of Steroid Biochemistry and Molecular Biology, 121(3-5), 491-497.
9. Thevis, M., et al. (2017). “Doping control analysis of anabolic steroids in equine urine
